Astrid Langer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Astrid Langer has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
J. John
Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Helmholtz-Zentrum München, Neuherberg, Deutschland
1 shared publication- Wolf Rogowski
Department of Health Care Management, Institute of Public Health and Nursing Research, Health Sciences, University of Bremen, Bremen, Germany
1 shared publication
Latest Publications
- Open Access
- 8 October 2010
- Published by Springer Nature in BMC Health Services Research
- Vol. 10 (1) , 283
A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?
A number of diagnostic tests are required for the detection and management of cancer. Most imaging modalities such as computerized tomography (CT) are anatomical. However, positron emission tomography (PET) is a functional diagnostic imaging technique using compounds labelled with positron-emitting radioisotopes to measure cell metabolism. It has been a useful tool in studying soft tissues such as the brain, cardiovascular system, and cancer. The aim of this systematic review is to critically summarize the health economic evidence of oncologic PET in the literature.
- 8 October 2010
- Published by Springer Nature in BMC Health Services Research
- Vol. 10 (1) , 283
Open AccessA systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?
A number of diagnostic tests are required for the detection and management of cancer. Most imaging modalities such as computerized tomography (CT) are anatomical. However, positron emission tomography (PET) is a functional diagnostic imaging technique using compounds labelled with positron-emitting radioisotopes to measure cell metabolism. It has been a useful tool in studying soft tissues such as the brain, cardiovascular system, and cancer. The aim of this systematic review is to critically summarize the health economic evidence of oncologic PET in the literature.
- 16 September 2010
- Published by Springer Nature in Der Onkologe
- Vol. 16 (10) , 992-1002
Kosteneffektivität diagnostischer Verfahren
- 16 September 2010
- Published by Springer Nature in Der Onkologe
- Vol. 16 (10) , 992-1002
Kosteneffektivität diagnostischer Verfahren
- 28 October 2009
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 157 (12) , 1230-1236
Newborn screening and health economics – a challenging relationship
- 28 October 2009
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 157 (12) , 1230-1236
Newborn screening and health economics – a challenging relationship
- Open Access
- 10 July 2009
- Published by Springer Nature in BMC Health Services Research
- Vol. 9 (1) , 115
Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers
Tissue engineering is an emerging field. Novel bioengineered skin substitutes and genetically derived growth factors offer innovative approaches to reduce the burden of diabetic foot and venous leg ulcers for both patients and health care systems. However, they frequently are very costly. Based on a systematic review of the literature, this study assesses the cost-effectiveness of these growth factors and tissue-engineered artificial skin for treating chronic wounds.
- 10 July 2009
- Published by Springer Nature in BMC Health Services Research
- Vol. 9 (1) , 115
Open AccessSystematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers
Tissue engineering is an emerging field. Novel bioengineered skin substitutes and genetically derived growth factors offer innovative approaches to reduce the burden of diabetic foot and venous leg ulcers for both patients and health care systems. However, they frequently are very costly. Based on a systematic review of the literature, this study assesses the cost-effectiveness of these growth factors and tissue-engineered artificial skin for treating chronic wounds.